François Santinon

In Vivo Expansion of Activated Foxp3+ Regulatory T Cells and Establishment of a Type 2 Immune Response upon IL-33 Treatment Protect against Experimental Arthritis

Jérôme Biton, Allan Thiolat, François Santinon et al. · The Journal of Immunology · 2016 · 55 citations · Full text

Life Sciences, Immunology, Pathobiology +17

Involvement of Tumor Necrosis Factor Receptor Type II in <i>FoxP3</i> Stability and as a Marker of Treg Cells Specifically Expanded by Anti–Tumor Necrosis Factor Treatments in Rheumatoid Arthritis

François Santinon, Maxime Batignes, Majda Lyna Mebrek et al. · Arthritis & Rheumatology · 2019 · 37 citations

Life Sciences, Immunology, Autoimmunity +16

Hydroxychloroquine (HCQ) decreases the benefit of anti-PD-1 immune checkpoint blockade in tumor immunotherapy

Janna Krueger, François Santinon, Alexandra Kazanova et al. · PLoS ONE · 2021 · 23 citations · Full text

Life Sciences, Immunology, Pharmacology +17

Direct AKT activation in tumor-infiltrating lymphocytes markedly increases interferon-γ (IFN-γ) for the regression of tumors resistant to PD-1 checkpoint blockade

François Santinon, Bennani Fatima Ezzahra, Meriem Bachais et al. · Scientific Reports · 2022 · 21 citations · Full text

Medicine, Immunology, Oncology +17